ROCKET PHARMACEUTICALS, INC. (RCKT) Net income 2016–2025
ROCKET PHARMACEUTICALS, INC. (RCKT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$223.1MFY2025 · since FY2016: -$7.6M → -$223.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$223.1M | +13.8% |
| FY2024 | -$258.7M | -5.4% |
| FY2023 | -$245.6M | -10.7% |
| FY2022 | -$221.9M | -31.2% |
| FY2021 | -$169.1M | -21.0% |
| FY2020 | -$139.7M | -80.8% |
| FY2019 | -$77.3M | -3.7% |
| FY2018 | -$74.5M | -280.6% |
| FY2017 | -$19.6M | -158.5% |
| FY2016 | -$7.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice